Table 2.
Crude percentages and adjusted odds for receiving chemotherapy among patients diagnosed with metastatic pancreatic cancer between 2007 and 2011 in the Netherlands (N = 5385)
| Crude percentage % | Multivariate odds ratio (95 % CI) | |
|---|---|---|
| Diagnosed in high-volume incidence centera | ||
| Yes | 26 | 1.14 (0.98–1.32) |
| No | 23 | 1.00 (reference) |
| Treated in high-volume treatment centera | ||
| Yes | 39 | 2.20 (1.85–2.61) |
| No | 21 | 1.00 (reference) |
| Diagnosed in high-volume surgical centera | ||
| Yes | 28 | 0.82 (0.64–1.07) |
| No | 23 | 1.00 (reference) |
aDifferent types of high-volume centers were added separately to the model adjusted for tumor and patient characteristics